Cite
In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
MLA
Tang, Na, et al. “In Vivo Evolution of Carbapenem Resistance in Hypervirulent Klebsiella Pneumoniae in a Patient Undergoing Long-Term Treatment.” Journal of Antimicrobial Chemotherapy (JAC), vol. 77, no. 2, Feb. 2022, pp. 531–33. EBSCOhost, https://doi.org/10.1093/jac/dkab380.
APA
Tang, N., Hu, J., Zhao, Y., Song, Y., Wang, C., Zhang, G., Wei, D., Fang, H., Li, C., Jia, R., & Feng, J. (2022). In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment. Journal of Antimicrobial Chemotherapy (JAC), 77(2), 531–533. https://doi.org/10.1093/jac/dkab380
Chicago
Tang, Na, Jinshu Hu, Yingying Zhao, Yuqin Song, Chao Wang, Gang Zhang, Dawei Wei, et al. 2022. “In Vivo Evolution of Carbapenem Resistance in Hypervirulent Klebsiella Pneumoniae in a Patient Undergoing Long-Term Treatment.” Journal of Antimicrobial Chemotherapy (JAC) 77 (2): 531–33. doi:10.1093/jac/dkab380.